Royal Bank Of Canada reaffirmed their buy rating on shares of LHC Group (NASDAQ:LHCG) in a research report released on Tuesday morning. They currently have a $69.00 price objective on the health services provider’s stock.

Other equities research analysts also recently issued reports about the company. Jefferies Group LLC reiterated a buy rating and set a $65.00 target price on shares of LHC Group in a report on Friday, June 9th. Benchmark Co. raised their price objective on LHC Group from $63.00 to $72.00 and gave the company a buy rating in a research note on Thursday, June 8th. Stephens set a $69.00 price objective on LHC Group and gave the company a buy rating in a research note on Saturday, May 6th. Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $59.00 target price for the company in a research report on Wednesday, April 19th. Finally, BidaskClub lowered LHC Group from a strong-buy rating to a buy rating in a research report on Wednesday, July 12th. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The stock has a consensus rating of Buy and a consensus target price of $64.38.

Shares of LHC Group (LHCG) traded down 0.47% during trading on Tuesday, hitting $63.05. The stock had a trading volume of 72,194 shares. The company has a market cap of $1.15 billion, a P/E ratio of 29.19 and a beta of 0.80. LHC Group has a one year low of $32.04 and a one year high of $69.35. The stock’s 50-day moving average price is $65.38 and its 200-day moving average price is $55.22.

COPYRIGHT VIOLATION NOTICE: “LHC Group’s (NASDAQ:LHCG) Buy Rating Reiterated at Royal Bank Of Canada” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/07/21/lhc-groups-nasdaqlhcg-buy-rating-reiterated-at-royal-bank-of-canada.html.

In related news, Director Coliseum Capital Management, L sold 8,632 shares of the firm’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $60.25, for a total value of $520,078.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the completion of the sale, the chief operating officer now directly owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last three months, insiders sold 682,839 shares of company stock worth $42,140,531. Company insiders own 14.80% of the company’s stock.

Several hedge funds have recently made changes to their positions in LHCG. BlackRock Inc. increased its stake in shares of LHC Group by 43,223.7% in the first quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after buying an additional 1,964,950 shares during the last quarter. FMR LLC increased its stake in shares of LHC Group by 14.1% in the first quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock valued at $87,312,000 after buying an additional 199,849 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of LHC Group by 3.9% in the first quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock valued at $77,185,000 after buying an additional 54,279 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of LHC Group by 2.7% in the first quarter. Dimensional Fund Advisors LP now owns 1,262,316 shares of the health services provider’s stock valued at $68,039,000 after buying an additional 32,771 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of LHC Group by 17.7% in the first quarter. Ameriprise Financial Inc. now owns 542,738 shares of the health services provider’s stock valued at $29,254,000 after buying an additional 81,554 shares during the last quarter. 84.56% of the stock is currently owned by institutional investors and hedge funds.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.